Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06811038 · ClinicalTrials.gov registry record · Phase 3
iCanQuit Smoking Cessation Among Hispanic Adults
A Phase 3 study, sponsored by Fred Hutchinson Cancer Center.
- Not yet
- Registry status
- Phase 3
- Development phase
- 854
- Enrollment target
NCT06811038 is a Phase 3 study that has not yet begun recruiting, run by Fred Hutchinson Cancer Center. The registered enrollment target is 854 participants.
The verdict
NCT06811038, a Phase 3 study, has not yet begun recruiting, sponsored by Fred Hutchinson Cancer Center.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 854 participants
- Enrollment target
Study Summary
This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.
Interventions
- OTHER Survey Administration
- DRUG Nicotine Patch
- DRUG Nicotine Lozenge
- DRUG Nicotine Gum
- DEVICE iCanQuit Smartphone App Smoking Cessation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 854 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2030-07-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06811038
The ClinicalTrials.gov registry entry for NCT06811038 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 854 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.
NCT06811038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06811038 about?
NCT06811038 is a clinical study titled "iCanQuit Smoking Cessation Among Hispanic Adults". This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with p...
What is the current status of trial NCT06811038?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 854 participants. The study started on 2026-08-15. Estimated completion is 2030-07-01.
What interventions are being tested in trial NCT06811038?
The interventions under investigation include: Survey Administration (OTHER), Nicotine Patch (DRUG), Nicotine Lozenge (DRUG), Nicotine Gum (DRUG), iCanQuit Smartphone App Smoking Cessation Program (DEVICE).
Who is sponsoring clinical trial NCT06811038?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.